Allstate Corp Royalty Pharma PLC Transaction History

Allstate Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $5,170 - $5,813	132 Added 1.01%	13,238 $523,000
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $153,234 - $180,550	4,083 Added 45.25%	13,106 $551,000
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $338,001 - $382,936	9,023 New	9,023 $352,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.